12:00 AM
 | 
Apr 22, 2013
 |  BC Week In Review  |  Company News  |  Deals

Eli Lilly, Siemens deal

Eli Lilly acquired two PET tracers from Siemens to image microtubule-associated protein tau (MAPT; tau; FTDP-17) tangles in the brain of Alzheimer's disease patients. Lilly will initially focus on incorporating the technologies into its R&D programs against

Read the full 193 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >